I posted the following on the Yahoo message board a few minutes ago...
We all agree that Sherrie sucks here as a manager. But, we can't do anything about it. We have less than six months to go until the PDUFA date, and with Sherrie being here for many years, there is no way that she would go "peacefully" when we are so close to the finish line. It would be best just to wait it out.
One point that I think pretty much all here are missing is that we all wish that ACUS had more funds so that we could easily get through the PDUFA date, and have a nice solid cash cushion in case of delays. But, when you consider the reason the stock price is so low, it is because of the fact that we are cutting this so close. If ACUS did have lots of funds, then the stock price would be much higher right now, and therefore we would have to spend a lot more to get the amount of shares we have today. The risk still stays the same for first time approval by the FDA, which most agree is about 60% chance for approval.
When you compare, if the stock price was considerably higher right now, then if we do see FDA approval first time around, our bounce will be a considerably smaller percentage jump in regards to the then current share price. But, with todays much much lower share price, FDA approval will still cause this to jump to the same price that it would have in the previous scenario, which would be a considerable higher percentage jump and cause us all to make more money because we could have bought signifacantly more shares with the same amount of funds. The downside, this is "make it or break it", if imagify recieves an "approvable letter" which wants more trials, then it's probably over, where as if we had this huge cash cushion, we could probably try for approval once more.
Example, share price is 2 bucks, and goes to 10 bucks on approval and we make 500% gain which is tremendous. Or, current share price is 40 cents and still goes to 10 bucks upon FDA approval first go around, and we make 2,500 percent gain which is absolutely phenominal and 5 times higher than the first scenario.
Basically, our current situation greatly increases our risk, but also tremendously increases our possible reward. Where as, if Sherrie was a good manager, our risk if seeing approval "some day" would be higher, but our possible reward would be significantly lower.
So all in all, if we do recieve FDA approval during February 2009, we will be better off in our current situation.
This is the way I look at it and just my personal opinion.
On a side note, delisting to the OTC:BB doesn't seem that bad to me either. It would cause the share price to fall significantly more, (which increases our payout if imagify recieves FDA approval if we purchase shares real low), and it also does not either increase or decrease our chances of approval.
Make it our break it is how I see it, with statistics SIGNIFICANTLY on our side.
If a guy were to invest a measly $4,000 dollars, and bought 10,000 shares then.....
40% chance of no approval = $0 dollars
60% chance of approval = $100,000 dollars (which assumes it goes to $10 upon approval)
Pretty much I see this as a lottery ticket play, and DO NOT INVEST IN THIS MORE THAN YOU CAN AFFORD TO LOSE!
All are just my personal opinions.
Market Data 
Markets 
AI
